Intergrated Generics Inc saidits Biopharmaceutics Inc subsidiary is in negotiations with amanufacturer and distributor of generic equivalents of brandname prescription drugs.    The company said a successful agreement would allow it todistribute chlorazepate dipotasssium, an anti-anxiety drug witha market potential of 80 mln dlrs.    Integrated said the licensor has asked for anonymity atthis time. Finalization of the agreement is expected within twoor three weeks, the company said. Reuter&#3;